# Amgen Inc. (AMGN) — Q4-2012 Earnings Results

**Report date:** 2013-01-23 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q4-2012

## Post-Earnings Brief

### Headline

Amgen Misses on EPS, Stock Down 0.26%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.40 | N/A | -1.96% |

### Management Commentary

**Tone:** Defensive

Overall, management expressed caution regarding current market conditions. They are prioritizing cost control while navigating challenges.

**Key quotes:**

> Management highlighted ongoing challenges in the market.

> They emphasized a focus on cost management and operational efficiency.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Amgen's earnings report showed a slight miss on EPS, which contributed to a modest decline in the stock price. Investors may be concerned about the lack of guidance and the challenges mentioned by management. The stock's reaction reflects a cautious sentiment in the market as the company navigates these issues.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q4-2012_